Quick Answer
RELMADA THERAPEUTICS, INC. reported Gross Profit of $1.1 thousand for fiscal year 2013.
RELMADA THERAPEUTICS, INC. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2013 | $1.1K | -49.0% |
| 2012 | $2.1K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| February 28, 2014 | -$3.00 | -100.6% | -101.8% |
| November 30, 2013 | $164.00 | -45.2% | -47.4% |
| May 31, 2013 | $312.00 | +188.9% | -35.3% |
| February 28, 2013 | $482.00 | -68.2% | +61.2% |
| November 30, 2012 | $299.00 | — | +176.9% |
| May 31, 2012 | $108.00 | — | -92.9% |
| February 29, 2012 | $1.5K | — | — |
- RELMADA THERAPEUTICS, INC. showed a decrease of -49.0% in Gross Profit compared to the prior fiscal year.
- Over the 2012–2013 period, RELMADA THERAPEUTICS, INC.’s gross profit has declined by 49.0% (from $2.1 thousand to $1.1 thousand).
- The most recent figure is from RELMADA THERAPEUTICS, INC.’s fiscal year 2013 report (Form 10-K), filed with the SEC on December 16, 2013.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: